✦ LIBER ✦

Characterization and quantification of pyridoxal 5'-phosphate-extracted nuclear progesterone receptor

✍ Scribed by Tong J. Chen; Richard G. MacDonald; William F. Robidoux Jr; Wendell W. Leavitt

Book ID: 116002337
Publisher: Elsevier Science
Year: 1981
Tongue: English
Weight: 678 KB
Volume: 14
Category: Article
ISSN: 0022-4731
DOI: 10.1016/0022-4731(81)90210-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extraction of nuclear glucocorticoid-rec

Extraction of nuclear glucocorticoid-receptor complexes with pyridoxal phosphate

✍ John A. Cidlowski; John W. Thanassi 📂 Article 📅 1978 🏛 Elsevier Science 🌐 English ⚖ 442 KB

Inactivation of avian progesterone recep

Inactivation of avian progesterone receptor binding to ATP-sepharose by pyridoxal 5′-phosphate

✍ Hideo Nishigori; V.K. Moudgil; David Toft 📂 Article 📅 1978 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Comparison of pyridoxal phosphate and 0.

Comparison of pyridoxal phosphate and 0.4 m KCl-extracted nuclear glucocorticoid receptors in HeLa S3 cells

✍ R.Alexander Currie; Teresa E. Budziak; John A. Cidlowski 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 864 KB

Nuclear progesterone receptors and chara

Nuclear progesterone receptors and characterization of cytosol receptors in the rat hypothalamus and anterior hypophysis

✍ Kato Junzo; Onouchi Tsuneko 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 1020 KB

Seizures induced by intracerebral admini

Seizures induced by intracerebral administration of pyridoxal-5′-phosphate: effect of GABAergic drugs and glutamate receptor antagonists

✍ P. Salazar; R. Tapia 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Synthesis and structure-activity relatio

Synthesis and structure-activity relationships of pyridoxal-6-arylazo-5′-phosphate and phosphonate derivatives as P2 receptor antagonists

✍ Yong-Chul Kim; Emidio Camaioni; Airat U. Ziganshin; Xiao-duo Ji; Brian F. King; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB 👁 2 views

Novel analogs of the P2 receptor antagonist pyridoxal-5′-phosphate-6-phenylazo-2′,4′disulfonate (PPADS) were synthesized. Modifications were made through functional group substitution on the sulfophenyl ring and at the phosphate moiety through the inclusion of phosphonates, demonstrating that a phos